Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation

ClinicalTrials.gov ID: NCT01278745

Public ClinicalTrials.gov record NCT01278745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 2:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)

Study identification

NCT ID
NCT01278745
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
362 participants

Conditions and interventions

Interventions

  • Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper) Biological
  • Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper) Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Aug 24, 2020

2011 – 2015

United States locations

U.S. sites
24
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Cedars Sinai Heart Institute Beverly Hills California 90211
Ronald Regan UCLA Medical Center Los Angeles California 90095
Stanford University/Palo Alto VA Palo Alto California 94304
University of California San Francisco San Francisco California 94143-0124
Stanford University Stanford California 94305
Northwestern University Chicago Illinois 60611
University of Maryland Baltimore Maryland 21201
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Minneapolis Heart Institute Minneapolis Minnesota 55407
University of Minnesota Minneapolis Minnesota 55455
Mount Sinai School of Medicine New York New York 10029
Columbia University Medical Center New York New York 10032'
Cleveland Clinic Foundation Cleveland Ohio 44195
Drexel University College of Medicine Philadelphia Pennsylvania 19102
University of Pennsylvania Philadelphia Pennsylvania 19104
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Medical University of South Carolina Charleston South Carolina 29425
Medical City Dallas Hospital/CRSTI Dallas Texas 75230
The Methodist Hospital Houston Texas 77030
Intermountain Medical Center Murray Utah 84157
University of Utah Salt Lake City Utah 84132-2401
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01278745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2020 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01278745 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →